200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Jaguar Health Enters Exchange Agreements for Preferred Stock
Reports First Quarter 2026 Financials
Jaguar Health Enters Uptown Series Q Exchange Agreement for $12.5M
Other Events
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
Reports 2025 Financials
Q1
Notice of Late Filing for Quarterly Report
FY 2025
Notice of Late Filing for Annual Report
Q3
Q2
Amended Annual Report
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Notice of Exempt Offering of Securities
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Submission Upload
Correspondence